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INTRODUCTION
In modern health care systems, the demands 
towards pharmacists (the most accessible medical 
professionals and a source of health information) are 
constantly rising. Pharmacy practice is increasingly 
focusing on patient consultation and patient care (1).
Of all the types of wounds, the most common 
and prevalent in the world are those from surgical in-
terventions. The results of a study of the prevalence 
of the different types of wounds show that the most 
common wounds in the world (112.4 million) are 
post-operative. Their share exceeds many times all 
the others, followed by skin ulcers – 37 000 000, and 
diabetic ulcers 14 500 000 (2). Most of the surgical 
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wounds are categorized as acute conditions that are 
treated without complications for an indefinite peri-
od of time (3). Patients are often unaware of the ex-
act way they have to treat their wounds at home. The 
healing process can be influenced by external and in-
ternal factors, resulting in complications and infec-
tions that slow the wound healing (4). 
Inappropriate wound healing leads to addition-
al treatment costs associated with the need for re-hos-
pitalization, additional medicinal products and con-
sumables, additional surgery, and in some cases may 
turn into a life-threatening condition (5). The large 
proportion of patients with post-operative wounds 
and the existing risks of complications determine 
the social significance of the problem and require the 
need for effective collaboration among all health pro-
fessionals (doctors, pharmacists, nurses, etc.).
As the most accessible healthcare profession-
als who have gained patients‘ trust (6), pharmacists 
ought to have the necessary knowledge and compe-
tencies related to all phases of the wound  healing 
process, innovative medical devices and appropriate 
dressings that facilitate the healing process and re-
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duce the risk of developing an infection. The knowl-
edge of wound healing and the opportunities to in-
fluence this dynamic and complicated process have 
increased significantly over the past few years (7). 
Regardless of the type of the wound and the degree 
of tissue loss, the healing of each wound takes place 
in phases that overlap in time and cannot be separat-
ed from one another (8). The international guides for 
wound healing are as follows: NICE, T.I.M.E., and 
Consensus Document of the World Union of Wound 
Healing Societies. In Bulgaria, no single consensus 
has yet been reached on the development of guid-
ance to help medical professionals (9-11). T.I.M.E. is 
a practical tool adapted to the phases of the wound 
process, assisting practitioners when assessing and 
making decisions for the treatment of patients with 
wounds. Each letter of the abbreviation corresponds 
to a particular process that is essential for the treat-
ment and progression of the wound process as fol-
lows: T (tissue management), I (inflammation and 
infection control), M (moisture balance), and E (epi-
thelial/edge/advancement) (12).
The wide variety of innovative wound medi-
cal devices on the market requires specific exper-
tise from medical professionals related to the prop-
er treatment and choice of appropriate dressing for 
each of the phases of the healing process. Based on 
the condition of the issue, we have developed a model 
for pharmaceutical care (PC) for consulting patients 
with post-operative wounds and to investigate the 
role of the pharmacist in optimizing the recovery of 
patients undergoing specialized PCs.
MATERIALS AND METHODS 
A documentary analysis was carried out with 
a reference to the available literature sources for 
wound healing - NICE, T.I.M.E., a consensus paper 
from the World Union of Wound Healing Societies. 
A model for PC, adapted for use by practicing phar-
macists based on the T.I.M.E. guideline, was devel-
oped to best fulfill the needs of pharmaceutical prac-
tice in our country.
The study was conducted in pharmacies on the 
territory of Varna with the cooperation of the Ortho-
pedic Department of the St. Anna University Hos-
pital, Varna. It covers the period of June to Septem-
ber, 2017.
Object and scope of the study were patients 
with postoperative wounds who had had a surgical 
intervention in the Orthopedic Department of the St. 
Anna University Hospital, Varna and were counseled 
by a pharmacist at a pharmacy following the steps of 
the developed algorithm, and a control group of pa-
tients who did not receive pharmaceutical care at a 
pharmacy, according to the model. Criteria for inclu-
sion were: patients in the Orthopedic Department of 
the St. Anna University Hospital with post-operative 
wounds irrespective of the location of the wound, the 
age of the patient, and the presence of a concomitant 
disease. Exclusion criteria included patients who re-
fused to participate in the study and patients who 
could not look after themselves and could not move 
alone.
The effectiveness of the PCs was evaluated by 
assessing the Life Value (LV) of the two patients 
groups. Patients‘ quality of life was measured by us-
ing the SF12 v2 generic tool (short form of SF 36). SF-
12V2 Health Survey is a validated Bulgarian ques-
tionnaire. It consists of 12 questions for assessing 
physical and mental health within the last 4 weeks. 
The results were measured with a software program 
provided by Optum, the product license holder. The 
participants responded to the questions from the pa-
per test handed to them after giving an unequivo-
cal consent and receiving instructions on how to fill 
their information in.
RESULTS
The developed PC model is adapted for use 
by actively working pharmacists on the basis of the 
T.I.M.E. guideline, adequately in line with the needs 
of the pharmaceutical practice in our country. The 
proposed algorithm mainly aims at choosing a thera-
peutic approach and appropriate dressing depending 
on the type and condition of the wound, and in case 
of suspicion of complications, the patients are imme-
diately referred to a physician consultation (Fig. 1).
The study involved a total of 58 people in a post-
operative recovery period with surgical wounds in 
different locations. Thirty-eight patients were con-
sulted on the proposed pharmaceutical care scheme, 
and 20 were the control group of unconsulted pa-
tients. The SF-12 v2 questionnaire is based on the 
Quality Metric 2009 Norming Study conducted in 
the United States in 2009 by the National Research 
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Corporation (NRC) based on which the scale used 
for the study was determined as well as the norm 
(50 points) for the investigated health indices with a 
minimum value of 20 and a maximum value of 80. 
Higher scores on the scale are an indicator of better 
quality of life.
Results of the quality of life tests of the con-
sulted and unconsulted patients with post-operative 
wounds are presented below.
In the group of pharmacist-consulted patients 
subject to specialized PC, it appeared that the men-
tal component summary (MCS) exceeded the estab-
lished norm. The individual components of men-
tal health that made up the indicator were above or 
matched exactly the norm. An exception was the 
emotional component RE, which could be explained 
by the recent intervention. Unlike MCS, the physi-
cal component summary (PCC) showed values be-
low the norm, with the highest general health (GH) 
component and the rest having approximately simi-
lar values (Fig. 2).
Figure 3 summarizes the physical and mental 
health assessments and the individual components, 
which were used in the quality of life test conducted 
in non-consulted patients.
The results for non-consulted patients were be-
low the norm for the individual indicators. Postoper-
ative patients with wounds, not advised by pharma-
cists, have been found to have reduced general phys-
ical functioning as well as reduced overall mental 
health indicators.
Fig. 1. Algorithm for therapeutic approach and choice of appropriate dressing
Fig. 2. Results of mental and physical health tests in con-
sulted patients with postoperative wounds
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The study results make it possible to detect the 
risk of developing depression in the study population 
at a total population rate of 20%.
The results obtained showed that 90% of pa-
tients not advised by a pharmacist were at risk of de-
veloping depression.
Patients under PC, who were consulted at a 
pharmacy, had very different results, with the risk 
of depression being only 2%. The distribution of pa-
tients with a risk of developing depression from the 
two study groups - consulted and non-consulted 
control group is presented in Figures 4 and 5.
Figure 6 and Figure 7 summarize the results for 
the assessment of physical (PCS) and mental (MCS) 
health in the study groups of patients compared to 
the generally established norm.
Reduced results were found for non-consulted 
patients, and for MCS and PCS. As shown in Figure 
7, in terms of physical health, 100% of the patients in-
cluded in the study were below the general norm and, 
in regard to mental health, 95% were below the estab-
lished norm.
In the case of the consulted patients it was 
found that 89% of the studied individuals had physi-
cal health below the norm. Unlike the non-consult-
ed, where 8% of the patients were within the norm 
for physical health and 3% were above the norm. Fig-
ure 6 shows that, in terms of mental health, 50% of 
respondents were within the norm, 45% were above 
Fig. 3. Results of a physical and mental health test con-
ducted on a non-consulted patients
Fig. 4. Risk of depression in consulted patients
Fig. 5. Risk of depression in unconsulted patients
Fig. 6. Physical and psychological status of consulted 
patients
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the norm, and only 5% were below the norm for men-
tal health.
For better illustration and evaluation of the in-
dicators in the two groups of patients - consulted and 
non-consulted by a pharmacist, the results are sum-
marized and compared in Figure 8.
The figure shows that the mental health level of 
the patients consulted was high and in some catego-
ries (VT, MH, SF), even above the universally estab-
lished norm. The difference in overall physical health 
indicators for both groups of patients was approxi-
mately 6 points in favor of those consulted, although 
both groups remained below the norm.
It is noteworthy that all the parameters of con-
sulted patients were better than those obtained in 
non-consulted patients.
DISCUSSION
The introduction of the concept of Pharmaceu-
tical Care in Pharmacy Practice places emphasis on 
the observation of the results of the applied treat-
ment (13).  With self-medication with over-the-coun-
ter (OTC) medicines, medical devices and more, 
much of the responsibility for patient health has been 
shifted to the pharmacists and their care (14).
Unconsulted patients with postoperative 
wounds showed poor quality of life on all tested pa-
rameters - general physical, mental health and social 
functions. The reduced result for PCS in both groups 
of patients is considered acceptable, based on their 
condition due to the recent surgery and the current-
ly impaired health. It should be noted that in spite of 
the lower PCS values  in the patients with the high-
est score, GH level is assumed to be a result of spe-
cialized PC.
The quality of life of pharmacist-consulted pa-
tients exceeded the average mental health indica-
tor and showed improvement in individual compo-
nents. An exception was RE, which we explain with 
the stress and discomfort of the recent interventions. 
Results from other studies have shown that special-
ists can improve the quality of life of patients (15,16). 
Postoperative patients with wounds, who had 
not been consulted by pharmacists, had significant-
ly impaired overall mental health in all components. 
For them, the risk of developing depression was ex-
tremely high, and low compliance and unsatisfactory 
end result of treatment could be expected. Poor com-
pliance can lead to a number of complications that 
may further aggravate the condition and increase the 
patient‘s treatment process.
The application of PC in pharmacies can not 
only improve the quality of life of patients, it may 
also prevent further complications, such as illnesses, 
as well as provide efficient and cost-effective treat-
ment (17,18).  
For the training of patients and improved com-
pliance, pharmacists should have the necessary 
knowledge and skills to know the appropriate medi-
cal devices and dressings  for each stage of the wound 
process, to recognize the symptoms of a developing 
wound complication so they can properly advise pa-
tients or refer them to a specialist physician when 
necessary.
CONCLUSION
Specialized PC in patients with post-operative 
wounds can contribute to the healing process in re-
Fig. 7. Physical and psychological status of unconsulted 
patients
Fig. 8. Comparative analysis of mental and physical health 
of consulted and non-consulted patients with postopera-
tive wounds
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gard to proper wound healing, rapid recovery and 
avoidance of complications, and hence improve the 
quality of life of patients after surgery.
Considering the social significance of the 
problem related to the treatment of post-operative 
wounds and the results for the improvement of the 
patients in specialized pharmaceutical care in QoL, it 
is necessary to create a basic guideline for our coun-
try, to help the medical specialists in the treatment 
and consultation of patients with wounds. Collabo-
ration between all specialists involved in the care of 
patients with postoperative wounds is also needed 
for improving the process of healing of patients with 
postoperative wounds.
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